Enhancing natural killer cell-mediated lysis of lymphoma cells by combining therapeutic antibodies with CD20-specific immunoligands engaging NKG2D or NKp30

Christian Kellner*, Andreas Günther, Andreas Humpe, Roland Repp, Katja Klausz, Stefanie Derer, Thomas Valerius, Matthias Ritgen, Monika Brüggemann, Jan G.J. van de Winkel, Paul W.H.I. Parren, Michael Kneba, Martin Gramatzki, Matthias Peipp

*Corresponding author for this work
12 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Enhancing natural killer cell-mediated lysis of lymphoma cells by combining therapeutic antibodies with CD20-specific immunoligands engaging NKG2D or NKp30'. Together they form a unique fingerprint.

Medicine & Life Sciences